Skip to Content
Newsletter Desktop Newsletter Mobile
August 28, 2019

How Krystal Biotech went from founding to IPO in 18 months

By Jayne Gest

CEO Krish Krishnan is an experienced biotech executive. But even he didn’t expect to go from self-funding Krystal Biotech to IPO in 18 months.

May 28, 2019

How to set up the right capital structure for each acquisition

Andrew Wiechkoske has never had the unfortunate experience of having a deal fall apart at or near the finish line, even though he’s worked at PNC since 2008 and completed more than $1 billion

October 25, 2018

A look into the wild world of raising capital

Three dealmakers with different experiences raising capital came together in a panel discussion at ASPIRE 2018 to discuss the ins and outs of funding.

June 25, 2018

A look at the Pittsburgh environment for raising capital

Four of Pittsburgh’s prominent business leaders share their experiences on the front lines of M&A in an environment of rising valuations. The higher prices are being driven in part by private equity-backed portfolio companies that buy strategically and do add-ons to other deals, as well as family offices with money to spend and a will to do direct acquisitions.